These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 36623804)

  • 1. Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder.
    Singewald N; Sartori SB; Reif A; Holmes A
    Neuropharmacology; 2023 Mar; 226():109418. PubMed ID: 36623804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders.
    Sartori SB; Singewald N
    Pharmacol Ther; 2019 Dec; 204():107402. PubMed ID: 31470029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
    Singewald N; Schmuckermair C; Whittle N; Holmes A; Ressler KJ
    Pharmacol Ther; 2015 May; 149():150-90. PubMed ID: 25550231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From recent advances in underlying neurocircuitry of fear and anxiety to promising pharmacotherapies for PTSD: The saga of heart, sex and the developing brain.
    Dabrowska J
    Neuropharmacology; 2023 Jul; 232():109529. PubMed ID: 37004751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder.
    Donnelly CL
    Child Adolesc Psychiatr Clin N Am; 2003 Apr; 12(2):251-69. PubMed ID: 12725011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of post-traumatic stress disorder (PTSD) and related comorbidities in clinical studies.
    Mureșanu IA; Grad DA; Mureșanu DF; Dobran SA; Hapca E; Strilciuc Ș; Benedek I; Capriș D; Popescu BO; Perju-Dumbravă L; Cherecheș RM
    J Med Life; 2022 Apr; 15(4):436-442. PubMed ID: 35646173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review.
    Burback L; Brémault-Phillips S; Nijdam MJ; McFarlane A; Vermetten E
    Curr Neuropharmacol; 2024; 22(4):557-635. PubMed ID: 37132142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for the treatment of anxiety.
    Murrough JW; Yaqubi S; Sayed S; Charney DS
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):393-406. PubMed ID: 26012843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.
    Purgato M; Gastaldon C; Papola D; van Ommeren M; Barbui C; Tol WA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011849. PubMed ID: 29975811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pragmatic randomised controlled trial of guided self-help versus individual cognitive behavioural therapy with a trauma focus for post-traumatic stress disorder (RAPID).
    Bisson JI; Ariti C; Cullen K; Kitchiner N; Lewis C; Roberts NP; Simon N; Smallman K; Addison K; Bell V; Brookes-Howell L; Cosgrove S; Ehlers A; Fitzsimmons D; Foscarini-Craggs P; Harris SRS; Kelson M; Lovell K; McKenna M; McNamara R; Nollett C; Pickles T; Williams-Thomas R
    Health Technol Assess; 2023 Nov; 27(26):1-141. PubMed ID: 37982902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.
    Melton H; Meader N; Dale H; Wright K; Jones-Diette J; Temple M; Shah I; Lovell K; McMillan D; Churchill R; Barbui C; Gilbody S; Coventry P
    Health Technol Assess; 2020 Sep; 24(43):1-312. PubMed ID: 32924926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
    Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
    Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing the Potential of Psychedelics for the Treatment of PTSD.
    Krediet E; Bostoen T; Breeksema J; van Schagen A; Passie T; Vermetten E
    Int J Neuropsychopharmacol; 2020 Jun; 23(6):385-400. PubMed ID: 32170326
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.